Document:

ex_97452.htm

Exhibit 4.12

 

CONSENT OF BOARD OF DIRECTORS OF HOVERING INTERNATIONAL HOLDINGS, INC. AUTHORIZING ISSUANCE OF SHARES

 

The undersigned, being all of the Directors of Hoverink International Holdings, Inc. a Delaware Corporation (the “Company”), hereby approve and adopt the following resolutions by unanimous consent effective this 20th day of ___October__, 2017.

 

WHEREAS, the Directors deem it necessary to raise up to Forty Million Dollars ($40,000,000.00) by making an offering of up to 2,000,000 common shares at $20.00 per share pursuant to an effective registration statement on Form S-1; and

 

WHEREAS, the Directors deem it necessary to register 4,550,000 common shares held by non-affiliate shareholders of the Company for resale in a secondary offering to facilitate the development of a public market in the Company’s shares once trading begins and 

 

WHEREAS, 100,000,000 shares of the Company’s common stock authorized to be issued and 36,772,000 have been issued; and

 

WHEREAS, the Company authorizes the officers of the Company to solicit purchases of the shares from qualified subscribers, 

 

THEREFORE, THE DIRECTORS UNANIMOUSLY CONSENT AS FOLLOWS:

 

RESOLVED, that the Chief Executive Officer shall cause an amended Registration Statement on       Form S-1 to be filed with the Securities and Exchange Commission with a Prospectus addressing both a primary offering of up to 2,000,000 common shares and a secondary offering of 4,550,000 common shares held by non-affiliate shareholders of the Company to facilitate the development of a public market in the shares once trading begins; and it is further

 

RESOLVED, that up to 2,000,000 shares shall be offered to qualified investors at $20,00 per share pursuant to the Company’s Registration Statement on Form S-1 when it becomes effective; and it is further

 

RESOLVED, that the President and Secretary are directed to cause the Company’s stock transfer agent Direct Transfer, LLC to issue certificates for the number of shares for which each subscriber in the primary offering has subscribed and paid in such denominations as the subscriber shall designate to the officers, which shares shall be deemed fully paid and non-assessable. 

 

 

 

	
			Debbie Mae Carter

				
			Director

				
			, 2017

			
	 	 	 
	
			Cyrus Sajna

				
			Director

				
			, 2017

			
	 	 	 
	
			Davidra Sajna

				
			Director

				
			, 201ex_97453.htm

Exhibit 4.13

 

HOVERINK BIOTECHNOLOGIES, INC. 

 

EIN# 46-3590875

 

 

 

BOARD OF DIRECTORS RESOLUTION TO GRANT RESTRICTED STOCK GRANT 

AWARDS TO EXECUTIVES, BOARD MEMBERS AND CONSULTANTS

 

Upon a duly made, seconded and unanimously adopted consent, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC adopted the following resolution it is hereby:

 

RESOLVED that, WHEREAS, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to DEBBIE MAE CARTER. as an effective means to align management interest with stockholder interests;

 

IT IS RESOLVED that, the following restricted shares are hereby granted

 

	
			Name of Grantee 

				Class of Stock	Number of Shares Granted 	Amount Vested 	
			Par Value

			
	
			 DEBBIE MAE CARTER

				
			Common

				
			6,800,000

				
			6,800,000

				
			$.0001

			
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	
			Total Shares Granted

				 	
			6,800,000

				
			 

				 

 

 

The undersigned, Debbie Carter, certifies that I am the duly appointed Chief Executive Officer of HOVERINK BIOTECHNOLOGIES, INC and that the above is a true and correct copy of resolutions duly adopted at a meeting of the directors thereof, convened and held in accordance with law and the Bylaws of HOVERINK BIOTECHNOLOGIES, INC and that such resolution is now in full force and effect.

 

IN WITNESS THEREOF, I have affixed my name as Secretary of HOVERINK BIOTECHNOLOGIES, INC and have attached the seal of HOVERINK BIOTECHNOLOGIES, INC to this resolution.

 

Dated The     Day Of

 

                                                         

Debbie Carter,

Chief Executive Officer, Treasurerex_97454.htm

Exhibit 4.14

 

HOVERINK BIOTECHNOLOGIES, INC. 

 

EIN# 46-3590875

 

 

 

BOARD OF DIRECTORS RESOLUTION TO GRANT RESTRICTED STOCK GRANT 

AWARDS TO EXECUTIVES, BOARD MEMBERS AND CONSULTANTS

 

Upon a duly made, seconded and unanimously adopted consent, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC adopted the following resolution it is hereby:

 

RESOLVED that, WHEREAS, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to CYRUS SAJNA. as an effective means to align management interest with stockholder interests;

 

IT IS RESOLVED that, the following restricted shares are hereby granted

 

	
			Name of Grantee

				Class of Stock	Number of Shares Granted	Amount Vested	
			Par Value

			
	
			 CYRUS SAJNA

				
			Common

				
			8,200,000

				
			8,200,000

				
			$.0001

			
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	
			Total Shares Granted

				 	
			 8,200,000

				
			 

				 

 

 

The undersigned, Debbie Carter, certifies that I am the duly appointed Chief Executive Officer of HOVERINK BIOTECHNOLOGIES, INC and that the above is a true and correct copy of resolutions duly adopted at a meeting of the directors thereof, convened and held in accordance with law and the Bylaws of HOVERINK BIOTECHNOLOGIES, INC and that such resolution is now in full force and effect.

 

IN WITNESS THEREOF, I have affixed my name as Secretary of HOVERINK BIOTECHNOLOGIES, INC and have attached the seal of HOVERINK BIOTECHNOLOGIES, INC to this resolution.

 

Dated The     Day Of

 

 

                                                        

Debbie Carter,

Chief Executive Officer, Treasurerex_97455.htm

Exhibit 4.15

 

HOVERINK BIOTECHNOLOGIES, INC. 

 

EIN# 46-3590875

 

 

 

BOARD OF DIRECTORS RESOLUTION TO GRANT RESTRICTED STOCK GRANT 

AWARDS TO EXECUTIVES, BOARD MEMBERS AND CONSULTANTS

 

Upon a duly made, seconded and unanimously adopted consent, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC adopted the following resolution it is hereby:

 

RESOLVED that, WHEREAS, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to DAVIDRA N. SAJNA. as an effective means to align management interest with stockholder interests;

 

IT IS RESOLVED that, the following restricted shares are hereby granted

                 

	
			Name of Grantee

				Class of Stock	Number of Shares Granted	Amount Vested	
			Par Value

			
	
			 DAVIDRA N. SAJNA

				
			Common

				
			6,900,000

				
			6,900,000

				
			$.0001

			
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	
			 Total Shares Granted

				 	
			 6,900,000

				
			 

				 

 

 

The undersigned, Debbie Carter, certifies that I am the duly appointed Chief Executive Officer of HOVERINK BIOTECHNOLOGIES, INC and that the above is a true and correct copy of resolutions duly adopted at a meeting of the directors thereof, convened and held in accordance with law and the Bylaws of HOVERINK BIOTECHNOLOGIES, INC and that such resolution is now in full force and effect.

 

IN WITNESS THEREOF, I have affixed my name as Secretary of HOVERINK BIOTECHNOLOGIES, INC and have attached the seal of HOVERINK BIOTECHNOLOGIES, INC to this resolution.

 

Dated The     Day Of

 

 

                                                       

Debbie Carter,

Chief Executive Officer, Treasurerex_97456.htm

Exhibit 4.16

 

 

HOVERINK BIOTECHNOLOGIES, INC. 

 

EIN# 46-3590875

 

 

 

BOARD OF DIRECTORS RESOLUTION TO GRANT RESTRICTED STOCK GRANT 

AWARDS TO EXECUTIVES, BOARD MEMBERS AND CONSULTANTS

 

Upon a duly made, seconded and unanimously adopted consent, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC adopted the following resolution it is hereby:

 

RESOLVED that, WHEREAS, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to DEBRA MAE CARTER. as an effective means to align management interest with stockholder interests;

 

IT IS RESOLVED that, the following restricted shares are hereby granted

    

	
			Name of Grantee

				Class of Stock 	Number of Shares Granted	Amount Vested	
			Par Value

			
	
			 DEBRA MAE CARTER

				
			Common

				
			4,500,000

				
			4,500,000

				
			$.0001

			
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	
			Total Shares Granted

				 	
			4,500,000

				
			 

				 

 

 

The undersigned, Debbie Carter, certifies that I am the duly appointed Chief Executive Officer of HOVERINK BIOTECHNOLOGIES, INC and that the above is a true and correct copy of resolutions duly adopted at a meeting of the directors thereof, convened and held in accordance with law and the Bylaws of HOVERINK BIOTECHNOLOGIES, INC and that such resolution is now in full force and effect.

 

IN WITNESS THEREOF, I have affixed my name as Secretary of HOVERINK BIOTECHNOLOGIES, INC and have attached the seal of HOVERINK BIOTECHNOLOGIES, INC to this resolution.

 

Dated The     Day Of

 

 

                                                       

Debbie Carter,

Chief Executive Officer, Treasurerex_97457.htm

Exhibit 4.17

 

CONSENT OF BOARD OF DIRECTORS OF 

 

HOVERINK BIOTECHNOLOGIES, INC. 

 

AUTHORIZING THE AMENDMENT OF OUR BYLAWS 

 

 

 

The undersigned, being all of the Directors of Hoverink International Holdings, Inc. a Delaware Corporation (the “Company”), hereby approve and adopt the following resolution by unanimous consent effective this ___ day of September 2017.

 

WHEREAS, the Board of Directors deem it necessary to Amend our Bylaws.

 

IT IS, THEREFORE, THE DIRECTORS UNANIMOUSLY:

 

RESOLVED, that the Board of Directors APPROVE of the amendment to the Bylaws of  HOVERINK BIOTECHNOLOGIES, INC. 

 

 

	
			Signature

				
			Capacity

				
			Date

			
	 	 	 
	
			Debbie Mae Carter

				
			Director

				
			September 13th 2017

			
	 	 	 
	 	 	 
	
			Cyrus Sajna

				
			Director

				
			September 13th 2017

			
	 	 	 
	 	 	 
	 	 	 
	
			Davidra Sajna

				
			Director

				
			September 13th 2017

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]